Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL)

CUSIP: 55083R104

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
19,277,111
Total 13F shares
152,354,676
Share change
+2,155,197
Total reported value
$81,758,597
Put/Call ratio
207%
Price per share
$0.54
Number of holders
111
Value change
+$815,972
Number of buys
37
Number of sells
40

Quarterly Holders Quick Answers

What is CUSIP 55083R104?
CUSIP 55083R104 identifies LYEL - Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL) as of Q1 2025

As of 31 Mar 2025, Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL) was held by 111 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 152,354,676 shares. The largest 10 holders included MWG Management Ltd., Foresite Capital Management IV, LLC, Orland Properties Ltd, BlackRock, Inc., Decheng Capital LLC, VANGUARD GROUP INC, Foresite Capital Management V, LLC, venBio Partners LLC, PRICE T ROWE ASSOCIATES INC /MD/, and Alphabet Inc.. This page lists 110 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.